Key Takeaways
- • Private equity acquisition of dental practices was not associated with higher negotiated reimbursement rates from insurers, suggesting PE-backed groups do not automatically exercise substantial market power in contracted pricing—a counterintuitive finding that complicates the narrative around PE consolidation in healthcare.
- • Post-acquisition strategy focuses on list price increases and care mix shift rather than payer negotiation, with PE-backed practices moving away from lower-cost preventive services toward more lucrative restorative procedures to drive revenue.
- • Competition, not ownership structure, emerges as the primary determinant of pricing discipline and patient value according to health economists cited in the analysis, reframing the policy debate away from PE presence and toward market concentration dynamics.
- • Dental market consolidation by private equity offers an instructive case study for understanding how financial ownership operates across fragmented healthcare sectors, with findings drawn from research conducted with American Dental Association affiliates.
Summary
The intensifying debate over private equity's role in healthcare has become bifurcated: critics argue that financial investors consolidate providers and inflate costs, while advocates contend that PE capital introduces management expertise and operational efficiency. However, research examining private equity's actual impact in specific markets reveals a more nuanced reality than either position captures.
An analysis of dental practice acquisitions by PE firms, conducted with colleagues affiliated with the American Dental Association, documents behavioral patterns that diverge from conventional consolidation narratives. The research uncovered a striking absence: private equity acquisition was not correlated with higher negotiated reimbursement rates secured from insurance payers. Had PE-backed dental groups possessed substantial market power—a hallmark of problematic consolidation—higher contracted prices would be the expected outcome. The absence of this finding suggests that PE ownership alone does not automatically translate into payer-side pricing power.
Instead, the documented strategy operates through alternative revenue mechanisms. After acquisition, PE-backed practices increase list prices (the nominal charges before insurance negotiation) and systematically shift the clinical service mix away from preventive care toward restorative procedures, which command higher per-unit reimbursement. This approach prioritizes revenue extraction through service selection rather than through direct negotiating leverage with insurers.
The broader implication challenges the primary framing of the PE-in-healthcare debate. According to health economists referenced in this analysis, the determining factor in pricing discipline and patient value is not ownership structure but the degree of competitive pressure in the market. Whether competition exists to constrain pricing and maintain focus on value for patients—regardless of whether providers are PE-backed—constitutes the underlying question that policy and regulation should address. The research suggests that the issue lies not inherently in private equity's participation in healthcare consolidation, but in the erosion of competitive alternatives within specific markets.
An analysis of dental practice acquisitions by PE firms, conducted with colleagues affiliated with the American Dental Association, documents behavioral patterns that diverge from conventional consolidation narratives. The research uncovered a striking absence: private equity acquisition was not correlated with higher negotiated reimbursement rates secured from insurance payers. Had PE-backed dental groups possessed substantial market power—a hallmark of problematic consolidation—higher contracted prices would be the expected outcome. The absence of this finding suggests that PE ownership alone does not automatically translate into payer-side pricing power.
Instead, the documented strategy operates through alternative revenue mechanisms. After acquisition, PE-backed practices increase list prices (the nominal charges before insurance negotiation) and systematically shift the clinical service mix away from preventive care toward restorative procedures, which command higher per-unit reimbursement. This approach prioritizes revenue extraction through service selection rather than through direct negotiating leverage with insurers.
The broader implication challenges the primary framing of the PE-in-healthcare debate. According to health economists referenced in this analysis, the determining factor in pricing discipline and patient value is not ownership structure but the degree of competitive pressure in the market. Whether competition exists to constrain pricing and maintain focus on value for patients—regardless of whether providers are PE-backed—constitutes the underlying question that policy and regulation should address. The research suggests that the issue lies not inherently in private equity's participation in healthcare consolidation, but in the erosion of competitive alternatives within specific markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.